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INTRODUCTION
Traditional Chinese medicines (TCMs) are commonly used
for a wide range of conditions in east Asian countries, includ-
ing Korea. TCMs contain heavy metals, such as arsenic, cad-
mium, mercury, and lead (1, 2). Of these, arsenic and lead can
cause hematologic changes, including anemia, neutropenia,
and thrombocytopenia (1, 2).
Exposure to arsenic compounds usually follows ingestion
or inhalation, and can occur during the occupational exposure
of metal workers or workers engaged in the manufacturing
or application of arsenical pesticides and herbicides, or non-
occupational exposure resulting from the ingestion of contam-
inated well water, dried milk, soy sauce, or moonshine whiskey
(3-5). Short-term arsenic poisoning may cause neuropathy
and intravascular hemolysis, while long-term exposure is asso-
ciated with the development of cancer (3-7).
Here, we report a severe hemolytic anemia induced by ar-
senic intoxication after the long-term ingestion of TCM.
CASE REPORT
A 51-yr-old woman was admitted to Chonnam National
University Hospital with exertional dyspnea and dizziness for
4 weeks. She also complained of tingling sensations in her
palms and soles that had been present for a long time. Her
family had no medical problems in the past. Twelve years
before the admission, she had been diagnosed as neurocysticer-
cosis with intermittent seizure attacks. Surgery was recom-
mended, but the patient refused and instead ingested TCMs
for about 12 yr intermittently. Recently, she had ingested
TCMs for 6 months because of seizures and did not ingest
further TCMs after the admission. There was no history of
illicit drug use, alcohol intake, or transfusion.
On the examination, the blood pressure, pulse, temperature
and respirations were 130/70 mmHg, 76/min, 36℃, and
20/min, respectively. She appeared chronically ill and had
anemic conjunctiva and scleral icterus. There was no palpa-
ble hepatosplenomegaly or lymphadenopathy.
She had a white cell count of 2.1×109/L (neutrophil: 54.7%,
lymphocyte: 31.6%, monocyte: 9.8%, eosinophil: 0.5%), with
platelets 107×109/L, a hemoglobin of 7.5 g/dL, and 11.5%
reticulocytes. Blood chemistry was revealed as follows: total
serum protein 6.6 g/dL, albumin 4.1 g/dL, alkaline phospha-
tase 62 IU/L, AST 132 IU/L, ALT 29 IU/L, total bilirubin
1.6 mg/dL (direct, 0.3 mg/dL), BUN 19.0 mg/dL, creatinine
0.7 mg/dL, and lactate dehydrogenase (LDH) 4,989 IU/L.
The serum haptoglobin was 7.25 mg/dL (normal range: 30
to 200 mg/dL), and there was a positive finding of urinary
hemosiderin. The coagulation profile revealed a prothrombin
time of 11.4 sec (control: 12.5 sec), a partial thromboplastin
time of 33.8 sec (control: 28 to 40 sec), and a fibrinogen level
of 158 mg/dL. Hepatitis A, B, and C virus antigens and anti-
Je-Jung Lee, Yeo-Kyeoung Kim,
Sang-Hee Cho, Kyeong-Soo Park, 
Ik-Joo Chung, Duck Cho*,
Dong-Wook Ryang*, Hyeoung-Joon Kim
Departments of Internal Medicine and Laboratory




Department of Internal Medicine, Chonnam National
University Medical School, 8 Hakdong, Dong-gu,
Gwangju 501-757, Korea
Tel : +82.62-220-6572, Fax : +82.62-225-8578
E-mail : hjoonk@chonnam.ac.kr
127
J Korean Med Sci 2004; 19: 127-9
ISSN 1011-8934
Copyright � The Korean Academy
of Medical Sciences
Hemolytic Anemia as a Sequela of Arsenic Intoxication Following
Long-Term Ingestion of Traditional Chinese Medicine
We report on a 51-yr-old woman who developed intravascular hemolytic anemia
caused by arsenic after long-term ingestion of a traditional Chinese medicine (TCM).
Twelve years before the admission, she was diagnosed as neurocysticercosis. She
has ingested a TCM for about 12 yr instead of undergoing medical therapy for the
disease. She was presented with a severe Coombs’-negative hemolytic anemia with
hemosiderinuria. The urine arsenic level was elevated suggesting the arsenic intox-
ication as a cause of the anemia. She was treated successfully with therapeutic red
cell exchange without any sequelae.
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Accepted : 19 April 2003bodies were all negative. Antinuclear antibodies, anti-Sm anti-
bodies, anti-DNA antibodies, anti-cardiolipin antibodies,
lupus anticoagulant, and anti- 2-glycoprotein I IgG were
all negative.
The peripheral blood smear showed polychromatophilia, ani-
socytosis, and macrocytosis. Both direct and indirect Coombs’
test results were negative. Osmotic fragility and glucose-6-
phosphate dehydrogenase activity were appropriate to the retic-
ulocyte count. Hemoglobin electrophoresis was normal. Sucrose
lysis and Ham’s test were negative. The serum ceruloplasmin
level and urine copper excretion were not elevated. A bone mar-
row biopsy showed a mild hypocellular marrow with 40%
cellularity and erythroid hyperplasia (Fig. 1). However, numer-
ous investigations failed to reveal a cause for the hemolysis.
She was treated empirically with prednisolone 1 mg/kg per
oral daily in three divided doses for 6 weeks, but there was no
improvements in the hemolytic anemia. Subsequently, four
sessions of plasma exchange were performed as a salvage ther-
apeutic intervention, resulting in mild improvement in the
hemolysis. We measured the levels of some heavy metals found
in TCMs. There was increased urinary excretion of arsenic
of 67.2  g/day (normal range; 0-25  g/day). Other heavy
metals included: serum cadmium 3.1  g/dL (0-10  g/dL),
serum lead 5  g/dL (0-60  g/dL), and urine lead 6  g/L (0-
150  g/L). Her hemolytic anemia improved gradually after
therapeutic red cell exchange of 450 mL. After 1 month, her
hemoglobin rose to 11.0 g/dL, and the reticulocyte count and
urinary excretion of arsenic decreased to 2.2% and 13.0  g/
day, respectively. Her clinical course is described in Table 1.
She is currently being followed monthly and there has been
no deterioration in her condition.
DISCUSSION
Our patient was initially presented with severe intravascular
hemolysis of unknown etiology. It is necessary to obtain a thor-
ough history from patients, but physicians in east Asian coun-
tries often encounter difficulties in taking past histories from
patients who frequently conceal traditional management me-
thod of diseases, including the ingestion of TCMs.
Arsenic intoxication mainly occurs through occupational
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At visit 10 days 20 days 40 days 50 days 60 days 70 days 90 days 100 days 110 days
Therapy PRD PE TRCE
Hb (g/dL) 5.7 6.1 7.3 6.2 7.3 6.1 6.9 7.5 11.0 12.2
Reticulocyte (%) 11.5 11.2 12.6 14.6 12.3 15.3 15.3 5.3 2.2 1.5
WBC (10
9/L) 2.1 4.8 6.6 3.1 4.4 3.4 5.1 6.7 4.5 4.2
Platelet (10
9/L) 107 120 139 104 128 96 107 111 127 257
LDH (g/dL) 2,982 2,783 2,712 5,085 4,576 4,019 2,840 1,588 483 452
Table 1. Hospital course of the patient: The hemolytic episode improved gradually after therapeutic red cell-exchange
PRD, prednisolone; PE, plasma exchange; TRCE, therapeutic red cell-exchange.
Fig. 1. Bone marrow biopsy shows mild hypocellular marrow with 40% cellularity (A) (H&E stain,×100) and erythroid hyperplasia (B) (H&E
stain,×400).
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exposure, including work with smelters, flue maintenance
operations, pesticides, herbicides, and preservatives. In addi-
tion, non-occupational exposure, such as ingestion of contam-
inated well water, dried milk, soy sauce, and moonshine whi-
skey, has the potential to cause arsenic intoxication (3, 4). The
arsenic compounds absorbed after ingestion or inhalation are
readily taken up by red blood cells and then deposited in the
liver, kidney, muscle, bone, skin, and hair (4).
Acute arsenic intoxication presents with gastrointestinal
symptoms (nausea, vomiting, or diarrhea), neurologic symp-
toms (peripheral neuropathy, seizure, or coma), and other man-
ifestations (facial edema, intravascular hemolysis, hepatome-
galy, renal failure, and circulatory collapse preceding death)
(4, 7). In chronic arsenic intoxication, skin, heart, lung, kid-
ney, hematopoietic system, and neurologic system can be
affected. Epidemiological studies have shown an association
between malignancies, such as lung cancer, leukemia, lym-
phoma, and angiosarcoma of the liver, and arsenic exposure
(3, 4, 8, 9). The hematologic manifestations of acute and
chronic arsenic intoxication include intravascular hemolysis,
leukopenia, and thrombocytopenia (3, 4).
Our patient ingested TCM for about 12 yr intermittently,
and continuously for the most recent 6 months. Although
hemolytic manifestations occur mainly in acute arsenic intox-
ication, it is unclear whether the hemolytic anemia in our
patient was induced by the recent or long-term ingestion of
TCMs. Her bone marrow hypocellularity, peripheral pancy-
topenia, and long-term peripheral neuropathy were thought
to reflect chronic intoxication for 12 yr. In contrast, the intra-
vascular hemolytic anemia was thought to reflect acute intoxi-
cation for the last 6 months. Our patient is therefore suggest-
ing to have coexisting acute and chronic intoxication.
The most useful laboratory test for confirming recent arsenic
exposure is the total urine arsenic level (1, 4, 10). Nonexposed
persons have levels below 10  g/g of creatinine (g Cr), while
persons exposed to 0.01 mg/ L have levels of 50  g/g Cr, and
acute poisoning is caused at 1,000  g/g Cr or higher levels
(4). Another diagnostic method for arsenic intoxication, espe-
cially the systemic absorption of arsenic, is measuring arsenic
levels in the hair and nails (3, 4). Therapeutic red cell-exchange
is used to treat patients with hemolytic anemia due to arsenic
intoxication, despite insufficient evidence of its effectiveness
(11). In addition, chelating agents, including D-penicillamine,
dimercaprol, dimercaptosuccinic, or dimercaptopanesulfonic
acid, used clinically in chronic arsenic poisoning, but the
chelating agents is not effective for treating established arseni-
cal peripheral neuropathies or arsine poisoning (3, 4).
Plasmapheresis given to our patient as an empirical treat-
ment was not an effective intervention for the arsenic intox-
ication. However, the therapeutic red cell-exchange resulted
in gradual improvement of her hemolytic anemia within a
few weeks without any complications. In this patient, we per-
formed the therapeutic red cell-exchange with half volume
of total red cell, as described a previous report in a patients
with malaria (12). 
In summary, we report a case of arsenic intoxication after
long-term ingestion of TCM presenting with intravascular
hemolysis that was treated successfully with therapeutic red
cell-exchange.
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